New York, NY (PRWEB) April 01, 2014
The prescription drug safety advocates at DrugRisk.com have added updated information to the site for patients who have used testosterone replacement therapy, or “low-T” drugs. A number of cases alleging the drugs caused heart attacks or stroke have been consolidated to a central federal court*.
DrugRisk is a free resource providing the latest warnings, safety alerts, recalls and litigation news to those taking popular prescription drugs. Visitors can see if others are experiencing similar side effects, avoid potential dangers and decide if they need legal advice.
Last year, more than 5.5 million men filled prescriptions for low-T drugs like AndroGel, Axiron and AndroDerm**. However, recent studies question their safety.
DrugRisk has added research from the National Institutes of Health and UCLA showing those over 65 or with a history of heart disease using low-T drugs had double the rate of heart attack***. Last year, the AMA cautioned the same patients may face a 29% increased rate of heart attacks, stroke or death from low-T drugs****
A number of patients have already filed a testosterone lawsuit in federal court alleging drugs like AndroGel caused heart attack or stroke without warning*****.
Now, DrugRisk has learned a Judicial Executive Committee has centralized at least 30 similar cases alleging heart attacks, strokes and other injuries from low-T drugs before U.S. District Judge Matthew F. Kennelly in the Northern District of Illinois.
Lawyers are offering help to those affected. Anyone who suffered a heart attack, stroke or cardiovascular event after using a low-T drug is urged to visit DrugRisk or speak with a lawyer about their legal rights as soon as possible. DrugRisk only recommends lawyers who have already handled testosterone lawsuits.
For more information on the research, side effects and litigation news related to testosterone drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.
*Northern District Illinois Executive Committee, 3/14/14; aboutlawsuits.com/wp-content/uploads/2014-03-14-Androgel-Order.pdf
**Bloomberg, 1/31/14; bloomberg.com/news/2014-01-31/heart-attack-risk-of-testosterone-drugs-under-u-s-review.html
***Public Library of Science, 1/29/14; plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0085805
****JAMA 11/5/13; media.jamanetwork.com/news-item/testosterone-therapy-following-coronary-angiography-associated-increased-risk-adverse-outcomes/
*****Bloomberg, 2/5/14; bloomberg.com/news/2014-02-05/abbott-labs-sued-by-five-men-claiming-androgel-injuries.html; Aurecchia v. AbbVie Inc., 14-cv-00772, U.S. Dist. Ct, Northern District of Illinois (Chicago); Marino v. AbbVie Inc., 14-cv-00777 U.S. Dist. Ct, Northern District of Illinois (Chicago)